1. Home
  2. OI vs AGIO Comparison

OI vs AGIO Comparison

Compare OI & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OI
  • AGIO
  • Stock Information
  • Founded
  • OI 1903
  • AGIO 2007
  • Country
  • OI United States
  • AGIO United States
  • Employees
  • OI N/A
  • AGIO N/A
  • Industry
  • OI Containers/Packaging
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • OI Consumer Discretionary
  • AGIO Health Care
  • Exchange
  • OI Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • OI 2.2B
  • AGIO 2.1B
  • IPO Year
  • OI N/A
  • AGIO 2013
  • Fundamental
  • Price
  • OI $12.60
  • AGIO $36.42
  • Analyst Decision
  • OI Buy
  • AGIO Buy
  • Analyst Count
  • OI 7
  • AGIO 6
  • Target Price
  • OI $16.71
  • AGIO $57.00
  • AVG Volume (30 Days)
  • OI 1.4M
  • AGIO 762.4K
  • Earning Date
  • OI 10-28-2025
  • AGIO 10-30-2025
  • Dividend Yield
  • OI N/A
  • AGIO N/A
  • EPS Growth
  • OI N/A
  • AGIO N/A
  • EPS
  • OI N/A
  • AGIO 11.13
  • Revenue
  • OI $6,482,000,000.00
  • AGIO $40,875,000.00
  • Revenue This Year
  • OI $1.94
  • AGIO $23.66
  • Revenue Next Year
  • OI $1.07
  • AGIO $143.65
  • P/E Ratio
  • OI N/A
  • AGIO $3.35
  • Revenue Growth
  • OI N/A
  • AGIO 30.57
  • 52 Week Low
  • OI $9.23
  • AGIO $23.42
  • 52 Week High
  • OI $16.04
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • OI 41.76
  • AGIO 47.14
  • Support Level
  • OI $12.56
  • AGIO $35.72
  • Resistance Level
  • OI $13.26
  • AGIO $37.18
  • Average True Range (ATR)
  • OI 0.36
  • AGIO 1.58
  • MACD
  • OI 0.02
  • AGIO -0.14
  • Stochastic Oscillator
  • OI 28.26
  • AGIO 44.29

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: